Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Nubeqa
Pharma
Bayer's new CEO Bill Anderson weighs structural change
In his first quarterly call since taking over as CEO, Anderson pointed to early 2024 as the period when the company could make structural changes.
Kevin Dunleavy
Aug 8, 2023 11:15am
Bayer needs acquisition to meet oncology sales goal, exec says
Jun 12, 2023 2:19pm
Bayer's Nubeqa, AZ's Forxiga pick up nods from UK's NICE
May 22, 2023 3:10pm
Bayer's potential blockbusters Nubeqa, Kerendia thrive in Q1
May 11, 2023 11:16am
Bayer sees Eylea slowdown continuing in '23
Feb 28, 2023 11:43am
J&J breaks out the blue jacket for prostate cancer awareness
Feb 7, 2023 7:35am